stage

AIN
XX Pharma Breakthrough XX

XX Pharma Breakthrough XX

location_on Queensland ,  Australien

Zur Beachtung:
Investments in Unternehmen sind riskant und sollten nur als Teil eines diversifizierten Portfolios erfolgen. Jedes Investment kann einen Totalverlust der Investitionssumme zur Folge haben. Diese Website richtet sich ausschließlich an Investoren, die ausreichend Erfahrung und Kompetenz haben, um die Risiken von Unternehmensinvestments zu verstehen und eigenverantwortlich Investmententscheidungen zu treffen. Sie sollten vor jedem Investment Ihre eigene kritische Analyse des jeweiligen Investmentangebotes durchführen.

Kurze Zusammenfassung

Implicit Bioscience is advancing IC14, a first-in-class antibody that switches off uncontrolled inflammation at its source, unlocking new treatments for ALS, acute respiratory distress, heart failure, and other diseases on the auto-immune scale

Highlights

  • First-in-Class global breakthrough in pharmaceticals most challenging space
  • Fully Established clinical safety in 8-year human and animal trial studies
  • World-class advisory panel, board and management team.
  • Substantial interest from 'Big Pharma' with several accessing our Data Room
  • Anticipated vastly shortened runway to commercialisation.

Übersicht

Ziel €2,800,000
Mindestinvestition €10,000
Erhaltenes Kapital €2,300,000
Vorherige Runden €5,700,000
Phase Vor Gründung / F&E - Phase
Investorenrolle Passiv

Eine Frage stellen
Haben Sie eine Frage?

Ähnliche Anzeigen

Technovate Business Pitch

Technovate Business Pitch

location_onNordosten, Vereinigte Staaten von Amerika

In a day and age where technology is at the height of everything we do, Technovate specializes in providing IT/Audio/Visual/Automation systems for residential homeowners and commercial businesses. Our solutions are tailored specifically to each client

  • Creating Long Lasting relationships.
  • Generating and exceeding revenue targets YOY.
  • Ensuring to create systems that are user friendly, and beneficial.

300.000 €

Erforderlicher Gesamtbetrag

85.000 €

Min pro Investor
Mehr erfahren
Marshall Papagos

Marshall Papagos

location_onGriechenland

Marshall Papagos is a newly designed flat-pack container based on composites and plastics, which is stealthy, lightweight, and addresses the defence and IMO Market. This new type revolutionises the logistics market in terms of cost and specification.

  • We have created from 2012 a mechanism of having EBITDA of 35%!
  • We have made a 1.1 return of Capital so far.
  • We have the strongest of Ties with MODs, NATO and have clients like DT!

5.800.000 €

Erforderlicher Gesamtbetrag

250.000 €

Min pro Investor
Mehr erfahren
Ostoform

Ostoform

location_onMidlands, Irland

Ostoform enables ostomy patients to live a life free from the worry of leaks and skin complications.

  • Product range developed and ready for commercial scale-up.
  • Distribution deals in place across 8 markets.
  • Reliable, recurring revenue streams in place.

2.000.000 €

Erforderlicher Gesamtbetrag

15.000 €

Min pro Investor
Mehr erfahren
Loading…
Loading the web debug toolbar…
Attempt #